AI-powered search
Try Polaris, our new AI-powered search!

Should baricitinib dosage be reduced when adequate response is achieved?

Featuring James Del Rosso, DO | Clinical Advisor |

Adjunct Clinical Professor, Dermatology
Touro University Nevada
Henderson, NV

| Published October 01, 2023